Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Do hospital staff understand the diabetes tech they prescribe?

NCT ID NCT07822945

Knowledge-focused Sponsor: Aristotle University Of Thessaloniki Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 16, 2026 · Last updated Sep 17, 2026 · Updated 1 time

Summary

Researchers at a university hospital in Thessaloniki, Greece, ask doctors and nurses to complete a questionnaire about diabetes technology. The survey covers diabetes types, blood sugar targets, insulin use, insulin pumps, and continuous glucose monitors. It aims to measure how much frontline staff know about the devices patients rely on, and where training may be lacking.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a questionnaire on diabetes technology knowledge
What this could lead to
If the survey finds gaps in knowledge, hospitals could use that information to design better training for staff who manage diabetes technology.
What could go wrong
This is a single-hospital survey of 112 staff, so the results may not reflect knowledge levels elsewhere. A questionnaire measures what people say they know, not how they actually perform in clinical care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 112 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Healthcare professionals practicing at the University General Hospital of Thessaloniki "AHEPA"

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All qualified and registered HCP practicing at the University General Hospital of Thessaloniki "AHEPA" , who were involved in direct patient care. * Actively working during the data collection period. Exclusion Criteria: * Administrative staff and personnel not directly involved in patient care. * HCP who declined to participate. * Participants who did not complete the questionnaire in full.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Continuous glucose monitoring system are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Continuous glucose monitoring system Continuous insulin infusion system Diabetes technology Insulin pump therapy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University General of Thessaloniki AHEPA

    RECRUITING

    Thessaloniki, 54636, Greece

More trials for these conditions

Other studies related to the condition(s) this trial covers.